Doctors in San Antonio are reporting a surge in cases of Respiratory Syncytial Virus (RSV) as the winter season approaches. RSV, which initially presents as mild, cold-like symptoms, can have serious consequences, especially for at-risk individuals. In response to the rise in cases, the Centers for Disease Control and Prevention (CDC) has issued a health advisory to doctors.
One of the major concerns highlighted in the advisory is the limited supply of nirsevimab, an antibody immunization for RSV. The shortage of nirsevimab can be attributed, in part, to production issues, as the medication was recently approved for manufacture. This shortage is causing alarm among healthcare professionals who rely on the antibody to prevent severe RSV cases in vulnerable patients.
University Health, a leading healthcare provider in San Antonio, has reported a significant increase in RSV cases. Their hospital’s virology report reveals a staggering 63% surge in RSV cases compared to previous years. The most vulnerable populations include older adults and children under one year old, who are at the highest risk of experiencing severe cases or complications from RSV.
Experts emphasize the importance of preventive measures, including regular handwashing and avoiding contact with sick individuals. Vaccines and the antibody immunization are also recommended forms of protection against RSV. However, due to the shortage of the long-acting monoclonal antibody, healthcare providers are only administering it to babies deemed to be at the highest risk.
One mother shared her harrowing experience with her nine-month-old daughter’s RSV diagnosis and subsequent recovery. She attests that staying alert to symptoms and seeking early medical care played a crucial role in her family’s ability to navigate the ordeal.
As winter brings an increase in RSV cases, healthcare providers in San Antonio are urging the public to remain vigilant. Following basic preventive measures, such as hand hygiene and avoiding close contact with sick individuals, can go a long way in curbing the spread of RSV. While the shortage of nirsevimab poses challenges, healthcare providers are committed to prioritizing its administration for those most in need.
“Social media scholar. Reader. Zombieaholic. Hardcore music maven. Web fanatic. Coffee practitioner. Explorer.”